Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126918 · ClinicalTrials.gov registry record · NA
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
A NA study, sponsored by Oregon Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 432
- Enrollment target
NCT01126918: Completed NA study, sponsored by Oregon Research Institute.
NCT01126918 is a NA study that has completed, run by Oregon Research Institute. The registered enrollment target is 432 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01126918, a NA study, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 432 participants
- Enrollment target
Study Summary
This three-site effectiveness trial will test whether a brief dissonance-based eating disorder prevention program produces intervention effects when college counselors, psychologists, and nurses are responsible for participant recruitment, screening, and intervention delivery under ecologically valid conditions.
Interventions
- BEHAVIORAL Body Project
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 432 participants |
| Start Date | 2010-04 |
| Est. Completion | 2016-02 |
| Phase | NA |
What the finished NCT01126918 record still lists
NCT01126918 is an interventional study that assigns participants to a tested intervention. The registered 432 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 1 intervention - of which Body Project is the first listed.
NCT01126918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01126918 about?
NCT01126918 is a clinical study titled "Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students". This three-site effectiveness trial will test whether a brief dissonance-based eating disorder prevention program produces intervention effects when college counselors, psychologists, and nurses are responsible for participant recruitment, screening, and intervention delivery under ecologically vali...
What is the current status of trial NCT01126918?
This trial is currently completed. It is a NA study. The enrollment target is 432 participants. The study started on 2010-04. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01126918?
The interventions under investigation include: Body Project (BEHAVIORAL).
Who is sponsoring clinical trial NCT01126918?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01126918's enrollment target sits among peer trials
432 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05271240 · 432 participants · Phase 3
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- NCT05365815 · 432 participants · NA
Melanated Group Midwifery Care (MGMC)
- NCT05499507 · 432 participants · NA
The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)
- NCT05806164 · 432 participants · Phase 4
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia